Startups
Delix Therapeutics
Delix Therapeutics develops non-hallucinogenic neuroplasticity-promoting medicines intended to restore neural connections in psychiatric and neurological disorders.
Team
David OlsonCo-Founder, Chief Innovation Officer, Head of the SAB |
Eliseo SalinasHead of Research and Development |
Mark RusChief Executive Officer |
 Matt GormanChief Financial Officer |
Retsina MeyerHead of Corporate Strategy |
Tricia McCallChief People Officer |